Cite
MLA Citation
Seval Ay et al.. “FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer.” Journal of chemotherapy, vol. 34, 2022, pp. 465–471. http://access.bl.uk/ark:/81055/vdc_100168592579.0x00002e